Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Izabela Mlynarczuk"'
Publikováno v:
Biomedical Papers, Vol 162, Iss 2, Pp 71-78 (2018)
Patients who are unable to receive oral medication (p.o.) are a major problem in outpatient settings, especially in home health care systems. Mucosal administration of drugs offers an alternative to the oral route, especially when the parenteral mode
Externí odkaz:
https://doaj.org/article/2d85f53e2d264df5a6d80669f4f72000
Autor:
Karol Borensztejn, Paweł Tyrna, Agata M. Gaweł, Ireneusz Dziuba, Cezary Wojcik, Lukasz P. Bialy, Izabela Mlynarczuk-Bialy
Publikováno v:
Cells, Vol 10, Iss 10, p 2569 (2021)
A phenomenon known for over 100 years named “cell-in-cell” (CIC) is now undergoing its renaissance, mostly due to modern cell visualization techniques. It is no longer an esoteric process studied by a few cell biologists, as there is increasing e
Externí odkaz:
https://doaj.org/article/e673bda44cee465a84b5b952e1569da3
Autor:
Izabela Mlynarczuk-Bialy, Thorsten R. Doeppner, Jakub Golab, Dominika Nowis, Grzegorz M. Wilczynski, Kamil Parobczak, Moritz E. Wigand, Malgorzata Hajdamowicz, Łukasz P. Biały, Olga Aniolek, Petra Henklein, Mathias Bähr, Boris Schmidt, Ulrike Kuckelkorn, Peter-M. Kloetzel
Publikováno v:
Translational Oncology, Vol 7, Iss 5, Pp 570-579 (2014)
Inhibition of the proteasome offers many therapeutic possibilities in inflammation as well as in neoplastic diseases. However, clinical use of proteasome inhibitors is limited by the development of resistance or severe side effects. In our study we c
Externí odkaz:
https://doaj.org/article/dac0949447534c1b883208e645e9afcb
Autor:
Jakub Włodarczyk, Julia Krajewska, Łukasz Szeleszczuk, Patrycja Szałwińska, Agata Gurba, Szymon Lipiec, Przemysław Taciak, Remigiusz Szczepaniak, Izabela Mlynarczuk-Bialy, Jakub Fichna
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 8; Pages: 7025
Inflammatory bowel diseases (IBD) and their main representatives, Crohn’s disease and ulcerative colitis, are worldwide health-care problems with constantly increasing frequency and still not fully understood pathogenesis. IBD treatment involves dr
Autor:
Ireneusz Dziuba, Agata M. Gawel, Paweł Tyrna, Jędrzej Machtyl, Monika Olszanecka, Andrzej Pawlik, Cezary Wójcik, Lukasz P. Bialy, Izabela Mlynarczuk-Bialy
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6819
Homotypic entotic figures, which are a form of “cell-in-cell” structures, are considered a potential novel independent prognostic marker in various cancers. Nevertheless, the knowledge concerning the biological role of this phenomenon is still un
Autor:
Szymon Lipiec, Agata Gurba, Izabela M. Agnieszczak, Andrzej Antoni Szczepankiewicz, Przemysław Szymański, Przemysław Taciak, Remigiusz Szczepaniak, Łukasz Szeleszczuk, Hanna Nieznanska, Jakub Włodarczyk, Jakub Fichna, Lukasz P. Bialy, Izabela Mlynarczuk-Bialy
Publikováno v:
Toxicology in Vitro. 88:105556
Publikováno v:
Acta Physica Polonica A. 139:3-7
Autor:
Alicja Sztokfisz-Ignasiak, Magdalena Tomczyk, Elżbieta Hejchman, Izabela Mlynarczuk-Bialy, Barbara Sowirka-Taciak, Jan Jankowski, Dorota Maciejewska, Hanna Kruszewska
Publikováno v:
Monatshefte für Chemie - Chemical Monthly. 150:255-266
18 (11 novel) Schiff bases, derivatives of salicylaldehyde, 2-hydroxyacetophenone, and 6-acetyl-, 8-acetyl-, and 8-formyl-7-hydroxy-4-methylcoumarin were synthesized and characterized by their spectral studies. 6-Acetyl-7-hydroxy-4-methylcoumarin was
Autor:
Lukasz P. Bialy, Andrzej A. Szczepankiewicz, Karol Borensztejn, Piotr Strus, Cezary Wojcik, Hanna Nieznanska, Izabela Mlynarczuk-Bialy, Zbigniew Czarnocki, Kamil Lisiecki
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 73
Podophyllotoxin (PPT) is an antimitotic drug used topically in the treatment of anogenital warts. Due to its toxicity it cannot be administered systemically as an anticancer agent. However, modified PPT derivatives such as etoposide and teniposide ar
Autor:
Jacek Malejczyk, Alicja Sztokfisz-Ignasiak, Izabela Mlynarczuk-Bialy, Aleksander P. Mazurek, Rafal Wyrebiak, Krzysztof Kubica, Agnieszka Czajkowska, Przemyslaw Taciak
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 75:903-910